InMed Pharmaceuticals Inc.
INM
$2.96
$0.24378.97%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.91M | -6.82M | -7.68M | -6.08M | -6.35M |
| Total Depreciation and Amortization | 576.70K | 600.20K | 604.60K | 603.70K | 602.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 219.30K | 368.60K | 454.50K | 156.50K | 150.20K |
| Change in Net Operating Assets | -174.90K | -790.60K | -369.30K | -1.30M | -737.80K |
| Cash from Operations | -7.29M | -6.64M | -6.99M | -6.61M | -6.34M |
| Capital Expenditure | 0.00 | -9.30K | -9.30K | -42.90K | -171.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing | 0.00 | -9.30K | -9.30K | -42.90K | -171.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.43M | 6.25M | 5.22M | 5.22M | 5.22M |
| Repurchase of Common Stock | -- | -- | -- | -- | -63.70K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -249.40K | -754.00K | -562.20K | -562.20K | -562.20K |
| Cash from Financing | 1.18M | 5.49M | 4.65M | 4.65M | 4.59M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.12M | -1.16M | -2.34M | -2.00M | -1.92M |